Product logins

Find logins to all Clarivate products below.


Breast Biopsy Devices | Medtech 360 | Market Analysis | Global | 2016

Moderate expansion of the global breast biopsy device market will be driven primarily by the increasing use of premium-priced VAB devices, as well as growth in procedure volumes resulting from women becoming more aware about the importance of breast cancer screening, especially in developing markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the breast biopsy device market in the US, Europe, and Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Biopsy Devices – Market Insights – Europe (Supplemental)
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – Europe
The European biopsy device market would be primarily driven by factors such as the expanding coverage for cancer screenings in the countries covered as well as updated recommendations to screening…
Report
Biopsy Devices – Market Insights – United States
The US biopsy device market has shown strong recovery from the impacts of the COVID-19 pandemic and is anticipated to resume prepandemic growth trends in the near term, with subsequent slow growth…
Report
Biosurgical Agents | Medtech 360 | Market Insights | US | 2024
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…